Chemical activators of V1RB4 operate through various signaling pathways to initiate the activation of this protein. Acetylcholine serves as an activator by binding to its specific receptor sites, which in turn triggers a change in the receptor's structure, leading to the activation of associated G-protein signaling pathways that ultimately activate V1RB4. Similarly, norepinephrine interacts with adrenergic receptors to form complexes that initiate downstream signaling cascades involving the activation of V1RB4. Glutamate and serotonin contribute to the activation of V1RB4 through their respective receptors, metabotropic glutamate receptors, and serotonin receptor subtypes, which, when bound by these neurotransmitters, propagate intracellular signals that lead to the activation of V1RB4.
Furthermore, histamine and dopamine engage with their respective receptors, histamine, and dopamine receptors, which modulate intracellular signaling pathways culminating in the activation of V1RB4. GABA, through its interaction with GABAergic receptors, initiates signaling cascades that are connected to V1RB4 activation pathways. Adenosine and ATP, by binding to purinergic receptors, set off a series of signaling events that activate V1RB4. Epinephrine, like norepinephrine, impacts adrenergic receptors to influence pathways leading to V1RB4 activation. Anandamide activates cannabinoid receptors, which are implicated in the signaling pathways that activate V1RB4. Lastly, nitric oxide engages with cellular targets to induce a signaling cascade, resulting in the activation of V1RB4. Through these diverse mechanisms, each chemical actively contributes to the functional state of V1RB4 by directly engaging with specific receptors and signaling pathways pertinent to this protein's activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine binds to adrenergic receptors that can form complexes with V1RB4, resulting in the activation of downstream signaling cascades that include V1RB4 activation. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate acts on metabotropic glutamate receptors which are linked to V1RB4 activation through intracellular signaling networks that converge on V1RB4's pathway. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Serotonin activates V1RB4 through its various serotonin receptor subtypes that, when bound, initiate signaling pathways resulting in V1RB4 activation. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine interacts with histamine receptors which modulate signaling pathways involving V1RB4, leading to its activation. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine binds to its receptors and can influence signaling pathways that include V1RB4, leading to the activation of V1RB4. | ||||||
GABA | 56-12-2 | sc-203053 sc-203053A sc-203053B sc-203053C | 10 g 25 g 5 kg 10 kg | $64.00 $136.00 $459.00 $765.00 | 2 | |
GABA's interaction with GABAergic receptors can initiate signaling cascades that lead to V1RB4 activation through connected pathways. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine, through its purinergic receptors, can initiate a signaling cascade that results in the activation of V1RB4. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, through adrenergic receptors, can influence pathways that lead to V1RB4 activation. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
ATP can bind to purinergic receptors and facilitate signaling pathways that result in the activation of V1RB4. | ||||||